PMN compared with EQ: revenue, margins and what each company keeps, and the suppliers and customers both name

PMNProMIS Neurosciences Inc.

Mkt capRevenueRevenue

EQEquillium, Inc.

Mkt capRevenueRevenue

Compare

PMNProMIS Neurosciences Inc.

EQEquillium, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

PMN1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▲+0.47%—

EQ1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±25.7%▲+17.41%×0.68

= impliedPMN realized, solidEQ realized, hatchedOne scale, both sides: full bar = 26%× = |realized| ÷ impliedSource: market data

PMNProMIS Neurosciences Inc.

3.46▼−68.74%· post 3.77

Mkt cap$29.7MRevenue—Revenue—

EQEquillium, Inc.

1.38▼−2.90%· post 1.38

ClosedOct 30 '26

Mkt cap$86.9MRevenue$4MQ4 FY24Revenue$41MFY24

Compare

ClosedOct 30 '26

PMNProMIS Neurosciences Inc.

EQEquillium, Inc.

3.46▼−68.74%post 3.77

Price

1.38▼−2.90%post 1.38

$29.7M

Mkt cap

$86.9M

—

Revenue

$4MQ4 FY24

—

Revenue

$41MFY24

PMN3.46▼−68.74%vsEQ1.38▼−2.90%ClosedOct 30 '26